Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class Non-VEGF-Targeted Therapeutics for Wet AMD ...
The Company announces that it has granted an aggregate of 10,600,000 stock options to directors, officers, employees and consultants in accordance with its Stock Option Plan. The options are ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Abstract: The quality of electromagnetic torque is an important factor in evaluating the operational performance of switched reluctance motors (SRMs). However, a conventional even-phase SRM cannot ...
Abstract: We proposed a DHM system with improved spatial resolution compared with that of the polarized camera-based DHM system by employing a liquid crystal phase modulator (LCPM). The LCPM-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results